Your Location:Home >Products >6108-05-0


  • Product NameLinocaine Hydrochloride
  • Molecular FormulaC14H25ClN2O2
  • Purity99%
  • Appearancewhite solid

Product Details

Quick Details

  • CasNo: 6108-05-0
  • Molecular Formula: C14H25ClN2O2
  • Appearance: white solid
  • Purity: 99%

Top Purity Linocaine Hydrochloride 6108-05-0 In Medicine

6108-05-0 Name


Linocaine hydrochloride


2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrate hydrochloride;N1-(2,6-dimethylphenyl)-N2,N2-diethylglycinamide hydrochloride hydrate;Linocaine hydrochloride(lidocaine HCL);LIDOCAINE HCL BP (INJECTABLE GRADE);Lignocaine monohydrate hydrochloride, Xylocaine monohydrate hydrochloride, 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide monohydrate hydrochloride;2-Dimethylamino-N-(2,6-dimethylphenyl)acetamide hydrochloride;Lidocaine Hydrochloride BP98 USP24;Lignocaine hydrochloride monohydrate


6108-05-0 Chemical & Physical Properties

Melting point 


Boiling point

350.8ºC at 760 mmHg

Molecular Formula


Molecular Weight


Flash Point






Exact Mass


Water Solubility

H2O: soluble


6108-05-0 Description

Lidocaine hydrochloride hydrate (Lignocaine hydrochloride hydrate) inhibits sodium channels involving complex voltage and using dependence. Lidocaine hydrochloride hydrate decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine hydrochloride hydrate is an amide derivative and has potential for the research of ventricular arrhythmia.


6108-05-0 Uses

Linocaine hydrochloride is a fast voltage-gated sodium channel blocker that used in Local anesthesia and heart rhythm disorders. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine.




7681-11-0 Relevant articles



Extremely bulky copper(i) complexes of [HB(3,5-{1-naphthyl}2pz)3]- and [HB(3,5-{2-naphthyl}2pz)3]- and their self-assembly on graphene


Van Dijkman, Thomas F.,De Bruijn, Hans M.,Brevé, Tobias G.,Van Meijeren, Bob,Siegler, Maxime A.,Bouwman, Elisabeth

, p. 6433 - 6446 (2017)

The synthesis and characterization, using NMR (1H and 13C), infrared spectroscopy, and X-ray crystallography, of the ethene and carbon monoxide copper(i) complexes of hydridotris(3,5-diphenylpyrazol-1-yl)borate ([Tp(Ph)2]-) and the two new ligands hydridotris(3,5-bis(1-naphthyl)pyrazol-1-yl)borate ([Tp((1Nt))2]-) and hydridotris(3,5-bis-(2-naphthyl)pyrazol-1-yl)borate ([Tp((2Nt))2]-) are described. X-ray crystal structures are presented of [Cu(Tp(Ph)2)(C2H4)] and [Cu(Tp((2Nt))2)(C2H4)].

Ion Exchange of Layered Alkali Titanates (Na2Ti3O7, K2Ti4O9, and Cs2Ti5O11) with Alkali Halides by the Solid-State Reactions at Room Temperature


Ogawa, Makoto,Saothayanun, Taya Ko,Sirinakorn, Thipwipa Tip

, p. 4024 - 4029 (2020/04/08)

Ion exchange of layered alkali titanates (Na2Ti3O7, K2Ti4O9, and Cs2Ti5O11) with several alkali metal halides surprisingly proceeded in the solid-state at room temperature. The reaction was governed by thermodynamic parameters and was completed within a shorter time when the titanates with a smaller particle size were employed. On the other hand, the required time for the ion exchange was shorter in the cases of Cs2Ti5O11 than those of K2Ti4O9 irrespective of the particle size of the titanates, suggesting faster diffusion of the interlayer cation in the titanate with lower layer charge density.


Relevant Products